OVARIAN ENDOMETRIOSIS: THE MODERN POSSIBILITIES OF RELAPSE PREDICTION

Эндометриоз яичников: Современные возможности прогнозирования рецидивов DOI: https://doi.org/10.37800/RM2020-1-30Ключевые слова: эндометриоз, эндометриоидные кисты яичников, рецидив, факторы риска, биомаркеры рецидива, овариальный резервАннотация В статье обобщены современные представления о факторах риска и механизмах развития рецидивов эндометриоза яичников, а также о потенциальных возможностях их прогноза с использованием генетических и молекулярно-биологических предикторов. Библиографические ссылки Bougie O., Yap M., Sikora L., Flaxman T., et al. Influence of race/ethnicity on prevalence and presentation of endometriosis: a systematic review and meta‐analysis. Bjog 2019, 126, 1104–1115. Chen L.C., et al. Risk of developing major depression and anxiety disorders among women with endometriosis: a longitudinal follow- up study. J. Affect. Disord. 190,282–285 (2016) Ramin - Wright A., et al. Fatigue - a symptom in endometriosis. Hum. Reprod. 33, 1459–1465 (2018). Soliman A.M., et al. The direct and indirect costs associated with endometriosis: a systematic literature review. Human Reproduction. 2016; 31(4):712-722. Оразов М.Р., Хамошина М.Б., Михалева Л.М. и др. Молекулярно-генетические особенности состояния эндометрия при эндометриоз-ассоциированном бесплодии. Трудный пациент. 2020; 1(18): 23-32. / Orazov M.R., Khamoshina M.B., Mikhaleva L.M., et al. Molekulyarno-geneticheskie osobennosti sostoyaniya endometriya pri endometrioz-associirovannom besplodii. Trudnyj pacient. 2020; 1(18): 23-32. (in Russian) Evans M.B., Decherney A.H. Fertility and endometriosis. Clin Obstet Gynecol. 2017; 60: 497–502. Cranney R., Condous G., Reid S. An update on the diagnosis, surgical management, and fertility outcomes for women with endometrioma. Acta Obstetricia et Gynecologica Scandinavica. 2017; 96(6), 633–643. doi:10.1111/aogs.13114 Muzii L., Di Tucci C., Di Feliciantonio M., et al. Management of Endometriomas. Semin Reprod Med. 2017;35(1) Llarena N., Flyckt R., Falcone T. Fertility Preservation in Women with Endometriosis Reproductive Health. Clinical Medicine Insights: Reproductive Health. 2019;13: 1–8. Exacoustos C., et al. Recurrence of endometriomas after laparoscopic removal: sonographic and clinical follow-up and indication for second surgery. Minim Invasive Gynecol. 2006;13(4): 281-288. Ozaki R., Kumakiri J., Tinelli A., et al. Evaluation of factors predicting diminished ovarian reserve before and after laparoscopic cystectomy for ovarian endometriomas: a prospective cohort study. J Ovarian Res. 2016; 9 (1): 37. doi: 10.1186 / s13048-016-0241-z. Muzii L., Achilli C., Lecce F., et al. Second surgery for recurrent endometriomas is more harmful to healthy ovarian tissue and ovarian reserve than first surgery. Fertil Steril. 2015; 103 (3): 738–743. Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update. 2009; 15 (4): 441-461. doi: 10.1093 / humupd / dmp007. Nirgianakis К., Ma L., McKinnon B., et al. Recurrence Patterns after Surgery in Patients with Different Endometriosis Subtypes: A Long-Term Hospital-Based Cohort Study. Journal of Clinical Medicine. 2020; 9(2), 496. doi:10.3390/ jcm9020496 Coccia M., Rizzello F., Palagiano A., et al. Long-term follow-up after laparoscopic treatment for endometriosis: multivariate analysis of predictive factors for recurrence of endometriotic lesions and pain. Eur J Obstet Gynecol Reprod Biol. 2011;(157): 78–83. Li X.Y., Chao X.P., Leng J.H., et al. Risk factors for postoperative recurrence of ovarian endometriosis: long-term follow-up of 358 women. Journal of Ovarian Research. 2019; 12(1). doi:10.1186/s13048-019-0552-y Hidari T., Hirata T., Arakawa T., et al. Contralateral ovarian endometrioma recurrence after unilateral salpingo-oophorectomy. BMC Women’s Health. 2019; 19(1). doi:10.1186/s12905-019-0760-z Liu X, Yuan L, Shen F. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol. 2007; 109: 1411-20. Coccia ME, Rizzello F, Palagiano A, et al. Long-term follow-up after laparoscopic treatment for endometriosis: multivariate analysis of predictive factors for recurrence of endometriotic lesions and pain. Eur J Obstet Gynecol Reprod Biol. 2011;157: 78–83. Guo, S.W. Recurrence of endometriosis and its control. Hum. Reprod. Update 2009. 15, 441–461. Vignali M., Bianchi S., Candiani M., et al. Surgical treatment of deep endometriosis and risk of recurrence. J. Minim. Invas. Gyn. 2005. 12, 508–513. Exacoustos C., Zupi E., Amadio A. Recurrence of endometriomas after laparoscopic removal: sonographic and clinical follow‐up and indication for second surgery. J. Minim. Invas. Gyn. 2006. 13, 281–288. Campo S, Campo V, Gambadauro P. Is a positive family history of endometriosis a risk factor for endometrioma recurrence after laparoscopic surgery? Reprod Sci. 2014;21:526–531. Nirgianakis K, McKinnon B, Imboden S, et al. Laparoscopic management of bowel endometriosis: resection margins as a pre- dictor of recurrence. Acta Obstet Gynecol Scand. 2014;93: 1262–1267. Seo JW, Lee DY, Yoon BK, et al. The age-related recurrence of endometrioma after conservative surgery. Eur J Obstet Gynecol Reprod Biol. 2017;(208):81–85. Selcuk S, Cam C, Koc N, Kucukbas M, Ozkaya E, Eser A, et al. Evaluation of risk factors for the recurrence of ovarian endometriomas. Eur J Obstet Gynecol Reprod Biol. 2016; (203):56–60. Lee SY, Kim ML, Seong SJ, et al. Recurrence of ovarian endometrioma in adolescents after conservative, laparoscopic cyst enucleation. J Pediatr Adolesc Gynecol. 2017;(30): 228–233. Koga K. et al. Recurrence of ovarian endometrioma after laparoscopic excision. Hum. Reprod. 2006; (21):2171-2174. Bozdag, G. Recurrence of Endometriosis: Risk Factors, Mechanisms and Biomarkers. Women’s Health. 2015; 11(5): 693–699. doi:10.2217/whe.15.56 Porpora MG, Pallante D, Ferro A, et al. Pain and ovarian endometrioma recurrence after laparoscopic treatment of endometriosis: a long-term prospective study. Fertil Steril. 2010;(93):716–721. Somigliana E, Viganò P, Benaglia L, et al. Ovarian stimulation and endometriosis progression or recurrence: a systematic review. Reprod Biomed Online. 2018; 38(2):185-194 Küçükbaş M, Kurek Eken M, Ilhan G, et al. Which factors are associated with the recurrence of endometrioma after cystectomy?. J Obstet Gynaecol. 2018;(38):372–376. Tobiume T, Kotani Y, Takaya H, et al. Determinant factors of postoperative recurrence of endometriosis: difference between endometrioma and pain. Eur J Obstet Gynecol Reprod Biol. 2016;(205):54–59. Muzii L, Bianchi A, Bellati F, et al. Histologic analysis of endometriomas: what the surgeon needs to know. Fertil Steril. 2007;87(2):362–6. Somigliana E, Benaglia L, Vercellini P, et al. Recurrent endometrioma and ovarian reserve: biological connection or surgical paradox? Am J Obstet Gynecol. 2011;204:525-529 Roman H. Endometriosis surgery and preservation of fertility, what surgeons should know. J Viscer Surg. 2018;(155):S31–S36. Brown J, Farquhar C. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2014;(3):CD009590. https://doi.org/10.1 002/14651858.CD009590.pub2. Shaltout M.F., Еlsheikhah A., Maged A.M., et al. A randomized controlled trial of a new technique for laparoscopic management of ovarian endometriosis preventing recurrence and keeping ovarian reserve. Journal of Ovarian Research. 2019; 12(1).doi:10.1186/s13048-019-0542-0 Hutchinson RW, George K, Johns D, et al. Hemostatic efficacy and tissue reaction of oxidized regenerated cellulose hemostats. Cellulose. 2013;20(1):537–45. Vercellini P, Somigliana E, Daguati R, et al. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol. 2008;198(5):504 e1–5. Muzii L, Di Tucci C, Achilli C, et al. Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;214(2):203–11. Jee BC, Lee JY, Suh CS, Kim SH, Choi YM, Moon SY. Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery. Fertil Steril. 2009;91(1):40–5. Vercellini P, Crosignani PG, Fadini R, et al. A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol. 1999;106(7):672–7. Lee S.R., Yi K.W., Song J.Y., et al. Efficacy and Safety of Long-Term Use of Dienogest in Women With Ovarian Endometrioma. Reproductive Sciences. 2018;25(3):341–346.doi:10.1177/1933719117725820 Kim MK, Chon SJ, Lee JH, et al. Postoperative Levonorgestrel-releasing intrauterine system insertion after gonadotropinreleasing hormone agonist treatment for preventing Endometriotic cyst recurrence: a prospective observational study. Reprod Sci (Thousand Oaks, Calif). 2018;25(1):39–43. Cho S, Jung JA, Lee Y, et al. Postoperative levonorgestrel- releasing intrauterine system versus oral contraceptives after gonadotropin-releasing hormone agonist treatment for preventing endometrioma recurrence. Acta Obstet Gyn Scan. 2014;93(1): 38-44. Адамян Л.В., ред. Эндометриоз: диагностика, лечение и реабилитация. Клинические рекомендации. М.; 2013. 90 с. (ed. by Adamyan L.V. Endometriosis: diagnosis, treatment and rehabilitation. Clinical guidelines. M.: 2013; 90 р. (In Russ.) Rahmioglu N., Nyholt D.R., Morris A.P., et al. Genetic variants underlying risk of endometriosis: insights from metaanalysis of eight genome‐wide association and replication datasets. Hum. Reprod. Update. 2014; 20(5): 702-16. https://doi. org/10.1093/humupd/dmu015. Мелкозерова ОА, Башмакова НВ, Окулова ЕО. Генетические и эпигенетические механизмы бесплодия, ассоциированного с генитальным эндометриозом. Акушерство и гинекология. 2019; 8:26-32. /Melkozerova OA, Bashmakova NV, Okulova E O. Genetic and epigenetic mechanisms of infertility associated with genital endometriosis. Obstetrics and gynecology. 2019; 8:26-32. (In Russian). Zhang L., Xiong W., Xiong Y., et al. 17β-Estradiol promotes vascular endothelial growth factor expression via the Wnt/β-catenin pathway during the pathogenesis of endometriosis. Mol. Hum. Reprod. 2016; 22(7): 526-35. Kokcu A. Relationship between endometriosis and cancer from current perspective. Arch Gynecol Obstet.2011;(284):1473-1479. Dyson M.T., Roqueiro D., Monsivais D., et al. Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis. PLoS Genet. 2014; 10(3): e1004158. https://doi.org/10.1371/journal.pgen.1004158. Colón-Díaz M., Báez-Vega P., García M., et al. HDAC1 and HDAC2 are differentially expressed in endometriosis. Reprod. Sci. 2012; 19(5): 483-92. https://doi.org/10.1177/1933719111432870. Samartzis E.P., Noske A., Samartzis N., et al. The expression of histone deacetylase 1, but not other class I histone deacetylases, is significantly increased in endometriosis. Reprod. Sci. 2013; 20(12): 1416-22. https://doi.org/10.1177/1933719113488450. Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocr Rev. 2019; 40(4): 1048-79. Bulun SE. Molecular biology of endometriosis: from aromatase to genomic abnormalities. Semin Reprod Med. 2015; 33(3):220-224. Attar E., et al. Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J Clin Endocrinol Metab. 2009;94(2): 623-631. Yuan L, Shen F, Lu Y, Liu X, Guo SW. Cyclooxygenase-2 overexpression in ovarian endometriomas is associated with higher risk of recurrence. Fertil. Steril. 2009; 91(4): 1303–1306 Han SJ, Jung SY, Wu SP, et al. Estrogen receptor beta modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell. 2015; 163:960–74. doi: 10.1016/j.cell.2015.10.034 Monsivais D, Dyson MT, Yin P, et al. Estrogen receptor β regulates endometriotic cell survival through serum and glucocorticoid-regulated kinase activation. Fertil Steril. 2016; 105:1266–73. doi: 10.1016/j.fertnstert.2016.01.012 Du Yu, Zhang Zh., Xiong W., et al.Estradiol promotes EMT in endometriosis via MALAT1/miR200s sponge function. Reproduction. 2018 Nov 1. pii: REP-18-0424.R2. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. Journal of Cellular Physiology. 2000;182 (3):311–22. Стрыгина В.А. Рецидивирующие эндометриоидные образования яичников. Морфофункциональное состояние. Автореф. дисс. канд. мед. наук. Москва; 2018/ Strygina V.A. Recidiviruyushchie endometrioidnye obrazovaniya yaichnikov. Morfofunkcional'noe sostoyanie.Avtoref. diss... kand. med. nauk. Moskva; 2018. (In Russian). Красильникова Л.В. Клинико- морфологические аспекты формирования эндометриоидных кист яичников. Автореф. дисс. канд. мед. наук. Москва; 2017/ Krasil'nikova L.V. Kliniko- morfologiсhеskie aspekty formirovaniya endometrioidnyh kist yaichnikov. Avtoref. diss. kand. med. nauk. Moskva; 2017. (In Russian). Sills E.S., Alper M.M., Walsh A.P. Ovarian reserve screening in infertility: practical applications and theoretical directions for research. Eur J Obstet Gynecol Reprod Biol.2009; 146(1):30-6. N. Wang, R. Huo, B. Cai, Y. Lu. Activation of Wnt/β-catenin signaling by hydrogen peroxide transcriptionally inhibits NaV 1.5 expression. Free Radical Biology and Medicine. 2016; 96: 34-44 Дополнительные файлы Опубликован Как цитировать Выпуск Раздел Лицензия Публикуемые в этом журнале статьи размещены под лицензией CC BY-NC-ND 4.0 (Creative Commons Attribution — Non Commercial — No Derivatives 4.0 International), которая предусматривает только их некоммерческое использование. В соответствии с этой лицензией пользователи имеют право копировать и распространять материалы, охраняемые авторским правом, но им не разрешается изменять или использовать их в коммерческих целях. Полная информация о лицензировании доступна по адресу https://creativecommons.org/licenses/by-nc-nd/4.0/.